David Bishop-Bailey - Publications

Affiliations: 
Royal Veterinary College, London, London, England, United Kingdom 

66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tracy AN, Yadavalli R, Reed KS, Parnaik R, Poulton NJ, Bishop-Bailey D, Fernández Robledo JA. Genome to phenome tools: In vivo and in vitro transfection of Crassostrea virginica hemocytes. Fish & Shellfish Immunology. PMID 32450301 DOI: 10.1016/J.Fsi.2020.05.022  0.312
2020 Edin ML, Lih FB, Hammock BD, Thomson S, Zeldin DC, Bishop-Bailey D. Vascular Lipidomic Profiling of Potential Endogenous Fatty Acid PPAR Ligands Reveals the Coronary Artery as Major Producer of CYP450-Derived Epoxy Fatty Acids. Cells. 9. PMID 32365470 DOI: 10.3390/Cells9051096  0.355
2019 Cho H, Yadav AK, Do Y, Heo M, Bishop-Bailey D, Lee J, Jang BC. Anti‑survival and pro‑apoptotic effects of meridianin C derivatives on MV4‑11 human acute myeloid leukemia cells. International Journal of Oncology. PMID 31789392 DOI: 10.3892/Ijo.2019.4925  0.551
2018 Park NS, Park YK, Ramalingam M, Yadav AK, Cho HR, Hong VS, More KN, Bae JH, Bishop-Bailey D, Kano J, Noguchi M, Jang IS, Lee KB, Lee J, Choi JS, et al. Meridianin C inhibits the growth of YD-10B human tongue cancer cells through macropinocytosis and the down-regulation of Dickkopf-related protein-3. Journal of Cellular and Molecular Medicine. PMID 30246484 DOI: 10.1111/jcmm.13854  0.559
2016 Moraes LA, Unsworth AJ, Vaiyapuri S, Ali MS, Sasikumar P, Sage T, Flora GD, Bye AP, Kriek N, Dorchies E, Molendi-Coste O, Dombrowicz D, Staels B, Bishop-Bailey D, Gibbins JM. Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 27758768 DOI: 10.1161/Atvbaha.116.308093  0.366
2016 Gilroy DW, Edin ML, De Maeyer RP, Bystrom J, Newson J, Lih FB, Stables M, Zeldin DC, Bishop-Bailey D. CYP450-derived oxylipins mediate inflammatory resolution. Proceedings of the National Academy of Sciences of the United States of America. PMID 27226306 DOI: 10.1073/Pnas.1521453113  0.368
2015 Kirkby NS, Reed DM, Edin ML, Rauzi F, Mataragka S, Vojnovic I, Bishop-Bailey D, Milne GL, Longhurst H, Zeldin DC, Mitchell JA, Warner TD. Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26183771 DOI: 10.1096/Fj.15-275065  0.314
2015 Thomson S, Edin ML, Lih FB, Davies M, Yaqoob MM, Hammock BD, Gilroy D, Zeldin DC, Bishop-Bailey D. Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins. Biochemical and Biophysical Research Communications. PMID 26086108 DOI: 10.1016/J.Bbrc.2015.06.012  0.446
2015 Bishop-Bailey D. Nuclear receptors in vascular biology. Current Atherosclerosis Reports. 17: 507. PMID 25772409 DOI: 10.1007/S11883-015-0507-8  0.39
2014 Faulkner A, Purcell R, Hibbert A, Latham S, Thomson S, Hall WL, Wheeler-Jones C, Bishop-Bailey D. A thin layer angiogenesis assay: a modified basement matrix assay for assessment of endothelial cell differentiation. Bmc Cell Biology. 15: 41. PMID 25476021 DOI: 10.1186/S12860-014-0041-5  0.313
2014 Bishop-Bailey D, Thomson S, Askari A, Faulkner A, Wheeler-Jones C. Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism. Annual Review of Nutrition. 34: 261-79. PMID 24819323 DOI: 10.1146/Annurev-Nutr-071813-105747  0.32
2014 Askari AA, Thomson S, Edin ML, Lih FB, Zeldin DC, Bishop-Bailey D. Basal and inducible anti-inflammatory epoxygenase activity in endothelial cells. Biochemical and Biophysical Research Communications. 446: 633-7. PMID 24631907 DOI: 10.1016/J.Bbrc.2014.03.020  0.412
2013 Bystrom J, Thomson SJ, Johansson J, Edin ML, Zeldin DC, Gilroy DW, Smith AM, Bishop-Bailey D. Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease? Plos One. 8: e75107. PMID 24058654 DOI: 10.1371/Journal.Pone.0075107  0.388
2013 Askari A, Thomson SJ, Edin ML, Zeldin DC, Bishop-Bailey D. Roles of the epoxygenase CYP2J2 in the endothelium. Prostaglandins & Other Lipid Mediators. 107: 56-63. PMID 23474289 DOI: 10.1016/J.Prostaglandins.2013.02.003  0.372
2012 Aihara K, Mogi M, Shibata R, Bishop-Bailey D, Reilly MP. Inflammation and vascular remodeling. International Journal of Vascular Medicine. 2012: 596796. PMID 23209907 DOI: 10.1155/2012/596796  0.356
2012 Thomson SJ, Askari A, Bishop-Bailey D. Anti-inflammatory effects of epoxyeicosatrienoic acids. International Journal of Vascular Medicine. 2012: 605101. PMID 22848834 DOI: 10.1155/2012/605101  0.474
2012 Swales KE, Moore R, Truss NJ, Tucker A, Warner TD, Negishi M, Bishop-Bailey D. Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress. Cardiovascular Research. 93: 674-81. PMID 22166712 DOI: 10.1093/Cvr/Cvr330  0.346
2011 Bishop-Bailey D. PPARs and angiogenesis. Biochemical Society Transactions. 39: 1601-5. PMID 22103494 DOI: 10.1042/Bst20110643  0.451
2011 Bystrom J, Wray JA, Sugden MC, Holness MJ, Swales KE, Warner TD, Edin ML, Zeldin DC, Gilroy DW, Bishop-Bailey D. Endogenous epoxygenases are modulators of monocyte/macrophage activity. Plos One. 6: e26591. PMID 22028915 DOI: 10.1371/Journal.Pone.0026591  0.325
2011 Caton PW, Holness MJ, Bishop-Bailey D, Sugden MC. PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. The Biochemical Journal. 437: 521-30. PMID 21609322 DOI: 10.1042/Bj20110702  0.413
2010 Kapoor A, Shintani Y, Collino M, Osuchowski MF, Busch D, Patel NS, Sepodes B, Castiglia S, Fantozzi R, Bishop-Bailey D, Mota-Filipe H, Yaqoob MM, Suzuki K, Bahrami S, Desvergne B, et al. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock. American Journal of Respiratory and Critical Care Medicine. 182: 1506-15. PMID 20693380 DOI: 10.1164/Rccm.201002-0240Oc  0.323
2010 Bishop-Bailey D. The platelet as a model system for the acute actions of nuclear receptors. Steroids. 75: 570-5. PMID 19778546 DOI: 10.1016/J.Steroids.2009.09.005  0.37
2009 Wray JA, Sugden MC, Zeldin DC, Greenwood GK, Samsuddin S, Miller-Degraff L, Bradbury JA, Holness MJ, Warner TD, Bishop-Bailey D. The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo. Plos One. 4: e7421. PMID 19823578 DOI: 10.1371/Journal.Pone.0007421  0.416
2009 Bishop-Bailey D, Bystrom J. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation. Pharmacology & Therapeutics. 124: 141-50. PMID 19615407 DOI: 10.1016/J.Pharmthera.2009.06.011  0.461
2009 Piqueras L, Sanz MJ, Perretti M, Morcillo E, Norling L, Mitchell JA, Li Y, Bishop-Bailey D. Activation of PPARbeta/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release. Journal of Leukocyte Biology. 86: 115-22. PMID 19389799 DOI: 10.1189/Jlb.0508284  0.426
2009 Bishop-Bailey D. Tumour vascularisation: a druggable target. Current Opinion in Pharmacology. 9: 96-101. PMID 19056315 DOI: 10.1016/J.Coph.2008.10.004  0.321
2009 Leontiou CA, Gueorguiev M, Hassan S, Van Der Spuy J, Lolli F, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Frohman LA, Chapple JP, Grossman AB, Korbonits M. AIP, a protein mutated in familial acromegaly, plays a role in the regulation of cell proliferation and shows cell-type specific subcellular localisation Hormone Research. 71: 149-150. DOI: 10.1159/000178061  0.306
2008 Bishop-Bailey D, Swales KE. The Role of PPARs in the Endothelium: Implications for Cancer Therapy. Ppar Research. 2008: 904251. PMID 19043612 DOI: 10.1155/2008/904251  0.417
2008 Bishop-Bailey D. A Role for PPARbeta/delta in Ocular Angiogenesis. Ppar Research. 2008: 825970. PMID 18382612 DOI: 10.1155/2008/825970  0.333
2008 Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. The Journal of Clinical Endocrinology and Metabolism. 93: 2390-401. PMID 18381572 DOI: 10.1210/Jc.2007-2611  0.305
2008 Bishop-Bailey D. Peroxisome proliferator-activated receptor beta/delta goes vascular. Circulation Research. 102: 146-7. PMID 18239142 DOI: 10.1161/Circresaha.107.170233  0.344
2008 Wray J, Bishop-Bailey D. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology. Experimental Physiology. 93: 148-54. PMID 17872966 DOI: 10.1113/expphysiol.2007.038612  0.317
2007 Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 2606-11. PMID 18029909 DOI: 10.1161/Atvbaha.107.152694  0.451
2007 Moraes LA, Swales KE, Wray JA, Damazo A, Gibbins JM, Warner TD, Bishop-Bailey D. Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets. Blood. 109: 3741-4. PMID 17213293 DOI: 10.1182/Blood-2006-05-022566  0.397
2007 Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 63-9. PMID 17068288 DOI: 10.1161/01.Atv.0000250972.83623.61  0.421
2006 Swales KE, Korbonits M, Carpenter R, Walsh DT, Warner TD, Bishop-Bailey D. The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Research. 66: 10120-6. PMID 17047076 DOI: 10.1158/0008-5472.Can-06-2399  0.369
2006 Bishop-Bailey D, Mitchell JA, Warner TD. COX-2 in cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 956-8. PMID 16627818 DOI: 10.1161/01.Atv.0000219672.68024.Bc  0.35
2006 Warner TD, Vojnovic I, Bishop-Bailey D, Mitchell JA. Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 542-4. PMID 16403783 DOI: 10.1096/Fj.05-4434Fje  0.301
2006 Ali FY, Davidson SJ, Moraes LA, Traves SL, Paul-Clark M, Bishop-Bailey D, Warner TD, Mitchell JA. Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 326-8. PMID 16368717 DOI: 10.1096/Fj.05-4395Fje  0.382
2006 Ali FY, Egan K, FitzGerald GA, Desvergne B, Wahli W, Bishop-Bailey D, Warner TD, Mitchell JA. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 34: 242-6. PMID 16239641 DOI: 10.1165/Rcmb.2005-0289Oc  0.374
2006 Moraes LA, Piqueras L, Bishop-Bailey D. Peroxisome proliferator-activated receptors and inflammation. Pharmacology & Therapeutics. 110: 371-85. PMID 16168490 DOI: 10.1016/J.Pharmthera.2005.08.007  0.478
2006 Murch O, Wray J, Collin M, Bishop-Bailey D, Thiemermann C. Lysophosphatidic Acid Reduces The Organ Injury Caused By Endotoxemia Via Activation Of G-Protein-Coupled Receptors, But Not Peroxisome Proliferator-Activated Receptor?? Shock. 25: 72. DOI: 10.1097/00024382-200606001-00218  0.342
2004 Bishop-Bailey D. FXR as a novel therapeutic target for vascular disease. Drug News & Perspectives. 17: 499-504. PMID 15605109 DOI: 10.1358/Dnp.2004.17.8.863693  0.344
2004 Warner TD, Vojnovic I, Giuliano F, Jiménez R, Bishop-Bailey D, Mitchell JA. Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues. The Journal of Pharmacology and Experimental Therapeutics. 310: 642-7. PMID 15148345 DOI: 10.1124/Jpet.103.063875  0.349
2004 Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proceedings of the National Academy of Sciences of the United States of America. 101: 3668-73. PMID 14990788 DOI: 10.1073/Pnas.0400046101  0.434
2003 Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, Mitchell JA, Warner TD. Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Molecular Pharmacology. 64: 923-31. PMID 14500749 DOI: 10.1124/Mol.64.4.923  0.392
2003 Bishop-Bailey D, Warner TD. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1925-7. PMID 12897060 DOI: 10.1096/Fj.02-1075Fje  0.481
2003 Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins & Other Lipid Mediators. 71: 1-22. PMID 12749590 DOI: 10.1016/S0090-6980(03)00003-0  0.416
2003 Patel HJ, Belvisi MG, Bishop-Bailey D, Yacoub MH, Mitchell JA. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. Journal of Immunology (Baltimore, Md. : 1950). 170: 2663-9. PMID 12594295 DOI: 10.4049/Jimmunol.170.5.2663  0.429
2002 Bishop-Bailey D, Hla T, Warner TD. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Circulation Research. 91: 210-7. PMID 12169646 DOI: 10.1161/01.Res.0000029080.15742.85  0.589
2002 Bishop-Bailey D, Calatayud S, Warner TD, Hla T, Mitchell JA. Prostaglandins and the regulation of tumor growth. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 21: 93-101. PMID 12086407 DOI: 10.1615/Jenvironpatholtoxicoloncol.V21.I2.20  0.615
2001 Inoue K, Kawahito Y, Tsubouchi Y, Yamada R, Kohno M, Hosokawa Y, Katoh D, Bishop-Bailey D, Hla T, Sano H. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer. Anticancer Research. 21: 2471-6. PMID 11724309  0.607
2000 Bishop-Bailey D, Hla T, Warner TD. Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line. British Journal of Pharmacology. 131: 651-4. PMID 11030710 DOI: 10.1038/Sj.Bjp.0703628  0.621
2000 Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. The Journal of Clinical Investigation. 106: 189-97. PMID 10903334 DOI: 10.1172/Jci9652  0.679
2000 Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. British Journal of Pharmacology. 129: 823-34. PMID 10696077 DOI: 10.1038/Sj.Bjp.0703149  0.453
2000 Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 164: 1364-71. PMID 10640751 DOI: 10.4049/Jimmunol.164.3.1364  0.594
1999 Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. Cyclooxygenase-1 and -2 isoenzymes. The International Journal of Biochemistry & Cell Biology. 31: 551-7. PMID 10399316 DOI: 10.1016/S1357-2725(98)00152-6  0.73
1999 Bishop-Bailey D, Hla T. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2. The Journal of Biological Chemistry. 274: 17042-8. PMID 10358055 DOI: 10.1074/Jbc.274.24.17042  0.617
1999 Bishop-Bailey D, Hla T, Mitchell JA. Cyclo-oxygenase-2 in vascular smooth muscle. International Journal of Molecular Medicine. 3: 41-8. PMID 9864384 DOI: 10.3892/Ijmm.3.1.41  0.581
1998 Bishop-Bailey D, Pepper JR, Larkin SW, Mitchell JA. Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: role of endogenous prostanoids. Arteriosclerosis, Thrombosis, and Vascular Biology. 18: 1655-61. PMID 9763540 DOI: 10.1161/01.Atv.18.10.1655  0.414
1998 Bishop-Bailey D, Burke-Gaffney A, Hellewell PG, Pepper JR, Mitchell JA. Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 249: 44-7. PMID 9705828 DOI: 10.1006/Bbrc.1998.8966  0.406
1998 Woods M, Bishop-Bailey D, Pepper JR, Evans TW, Mitchell JA, Warner TD. Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells. Journal of Cardiovascular Pharmacology. 31: S348-50. PMID 9595478 DOI: 10.1097/00005344-199800001-00097  0.334
1998 Trifan OG, Bishop-Bailey D, Hla T. Inducible cyclooxygenase-2 overexpression using the ecdysone-inducible gene expression system Faseb Journal. 12: A1384.  0.704
1997 Bishop-Bailey D, Pepper JR, Haddad EB, Newton R, Larkin SW, Mitchell JA. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arteriosclerosis, Thrombosis, and Vascular Biology. 17: 1644-8. PMID 9327757 DOI: 10.1161/01.Atv.17.9.1644  0.323
1997 Bishop-Bailey D, Larkin SW, Warner TD, Chen G, Mitchell JA. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. British Journal of Pharmacology. 121: 125-33. PMID 9146896 DOI: 10.1038/Sj.Bjp.0701100  0.376
1994 Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proceedings of the National Academy of Sciences of the United States of America. 91: 2046-50. PMID 7510883 DOI: 10.1073/Pnas.91.6.2046  0.327
Show low-probability matches.